Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 4
2014 7
2015 4
2016 1
2017 2
2018 2
2020 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.
Berman DM, Lee AY, Lesurf R, Patel PG, Ebrahimizadeh W, Bayani J, Lee LA, Boufaied N, Selvarajah S, Jamaspishvili T, Guérard KP, Dion D, Kawashima A, Clarke GM, How N, Jackson CL, Scarlata E, Siddiqui K, Okello JBA, Aprikian AG, Moussa M, Finelli A, Chin J, Brimo F, Bauman G, Loblaw A, Venkateswaran V, Buttyan R, Chevalier S, Thomson A, Park PC, Siemens DR, Lapointe J, Boutros PC, Bartlett JMS. Berman DM, et al. Among authors: ebrahimizadeh w. J Urol. 2023 Aug;210(2):257-271. doi: 10.1097/JU.0000000000003507. Epub 2023 May 1. J Urol. 2023. PMID: 37126232
Mutational screening of the NR5A1 in azoospermia.
Zare-Abdollahi D, Safari S, Mirfakhraie R, Movafagh A, Bastami M, Azimzadeh P, Salsabili N, Ebrahimizadeh W, Salami S, Omrani MD. Zare-Abdollahi D, et al. Among authors: ebrahimizadeh w. Andrologia. 2015 May;47(4):395-401. doi: 10.1111/and.12274. Epub 2014 Apr 20. Andrologia. 2015. PMID: 24750329
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.
Ebrahimizadeh W, Guérard KP, Rouzbeh S, Scarlata E, Brimo F, Patel PG, Jamaspishvili T, Hamel L, Aprikian AG, Lee AY, Berman DM, Bartlett JMS, Chevalier S, Lapointe J. Ebrahimizadeh W, et al. Br J Cancer. 2023 Jun;128(12):2165-2174. doi: 10.1038/s41416-023-02236-8. Epub 2023 Apr 10. Br J Cancer. 2023. PMID: 37037938 Free PMC article.
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.
Dorigo O, Oza AM, Pejovic T, Ghatage P, Ghamande S, Provencher D, MacDonald LD, Torrey H, Kaliaperumal V, Ebrahimizadeh W, Hirsch HA, Bramhecha Y, Villella J, Fiset S. Dorigo O, et al. Among authors: ebrahimizadeh w. Clin Cancer Res. 2023 Aug 1;29(15):2808-2815. doi: 10.1158/1078-0432.CCR-22-2595. Clin Cancer Res. 2023. PMID: 37126016 Free PMC article. Clinical Trial.
A novel nanobody against urease activity of Helicobacter pylori.
Ardekani LS, Gargari SL, Rasooli I, Bazl MR, Mohammadi M, Ebrahimizadeh W, Bakherad H, Zare H. Ardekani LS, et al. Among authors: ebrahimizadeh w. Int J Infect Dis. 2013 Sep;17(9):e723-8. doi: 10.1016/j.ijid.2013.02.015. Epub 2013 Apr 3. Int J Infect Dis. 2013. PMID: 23561799 Free article.
25 results